Search

According to WHO and ECDC data, 161,569 cases were reported in 2024 across 51 of the 53 countries in the European region, equivalent to 17.2 cases per 100,000 inhabitants.

Recent data from an ongoing study in first-line AML showed a 100% overall response rate (ORR) with iadademstat in combination with venetoclax and azacitidine.

Spain Prime Minister, Pedro Sánchez, recently visited the first maximum biosafety level (BSL-4) laboratory in Spain, located in Tres Cantos (Madrid). It is the world's only facility of its kind

Our Director General, Ion Arocena, participated in the latest meeting of the MEP Interest Group “EU Biotech and Life Sciences Alliance” with the aim of bringing clarity and guidance to the European

Joan Perelló and Arturo Urrios will lead a new vertical focused on company creation and early-stage biotech projects, with a strong focus on Spain.

Meet Arquea Biological Innovations, our new member. We spoke with Fernando Garcia Osorio, CEO.

Meet Macami Biotech, our new member. We spoke with Miguel Rodríguez-Villa Förster, CEO.

The biotech company GAT Therapeutics, based at the University of Barcelona Parc Científic de Barcelona (PCB-UB), is making progress in the development of GTX-11, a new oral drug candidate for the

The conference was organised by the UAI (Innovation Support Unit) of the IiSGM (Gregorio Marañón Health Research Institute) and was sponsored by GENESIS Biomed, HOFFMANN EITLE, DINAMIZA Health

Key combination for the treatment of Small Cell Lung Cancer.

We interviewed Pedro Martínez, Councilor for Economic Promotion at the Salamanca City Council, to learn about the potential of its ecosystem and the opportunities the Green Innovation Forum offers for

Meet Phoenix Biosolutions, our new member. We spoke with Carlos Rodríguez-Villa Förster, CEO.

The Spanish Bioindustry Association (AseBio) has organized a conference at the Ministry of Science that brought together leading institutional, political, and industry stakeholders to present a

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow. Data presented at AGBT demonstrates TruPath Genome's accuracy in detecting rare genetic disease. Broad